Bio-Rad Laboratories Inc Class A (BIO)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
LABORATORY ANALYTICAL INSTRUMENTS
CEO:
Norman D. Schwartz
Employees:
7,900
1000 ALFRED NOBEL DRIVE, HERCULES, CA 94547
5107247000

Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, sells, and markets a range of reagents, apparatus, and laboratory instruments. The clinical Diagnostics segment offers test systems, informatics systems, test kits, and specialized quality controls for clinical laboratories.

Data derived from most recent annual or quarterly report
Market Cap 11.294 Billion Shares Outstanding24.749 Million Avg 30-day Volume 197.832 Thousand
P/E Ratio5.365 Dividend Yield0.0 EPS-121.79
Price to Revenue7.8097 Debt to Equity0.0008 EBITDA524.358 Million
Price to Book Value1.6678 Operating Margin17.119899999999998 Enterprise Value7.573 Billion
Current Ratio2.923 EPS Growth0.114 Quick Ratio1.9
1 Yr BETA 1.0303 52-week High/Low 607.54 / 344.63 Profit Margin145.5669
Operating Cash Flow Growth14.4438 Altman Z-Score4.7422 Free Cash Flow to Firm 1.293 Billion
Earnings Report2023-05-04

Are you looking for this stock instead?

View SEC Filings from BIO instead.

View recent insider trading info

Bio-Rad Laboratories Inc Class A YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding BIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding BIO

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2023-02-14 by RAMALINGAM AJIT
  • 4: filed on 2022-12-19 by WRIGHT DARA
  • 4: filed on 2022-12-07 by SCHWARTZ STEVEN D
  • 4: filed on 2022-12-01 by SCHWARTZ NORMAN D
  • 4: filed on 2022-11-28 by ALLISON SCHWARTZ
  • 4: filed on 2022-11-14 by RAMALINGAM AJIT
  • 4: filed on 2022-09-07 by WRIGHT DARA
  • 4: filed on 2022-09-07 by SCHWARTZ NORMAN D
  • 4: filed on 2022-09-07 by ALLISON SCHWARTZ
  • 4: filed on 2022-09-07 by RAMALINGAM AJIT

    • Events (8k)

  • 8-K: filed on 2023-02-23:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2023-02-16:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-10:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-08:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-10-27:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-28:
    Item 2.02: Results of Operations and Financial Condition
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-05-18:
    Item 7.01: Regulation FD Disclosure
  • 8-K: filed on 2022-04-28:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2022-04-20:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-28:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    1.7 Thousand total shares from 2 transactions

    Exercise Derivative Conversion (M)

    1 Thousand total shares from 2 transactions

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    ERNST TIMOTHY S EVP, GENERAL COUNSEL & SEC

    • Officer
    		 2,671 2023-03-08 3

    RAMALINGAM AJIT SVP, CHIEF ACCOUNTING OFFICER

    • Officer
    		 0 2023-02-10 6

    WRIGHT DARA EXECUTIVE VICE PRESIDENT

    • Officer
    		 2,767 2022-12-16 3

    SCHWARTZ STEVEN D

    • 10% Owner
    		 4,462,046 2022-11-07 1

    SCHWARTZ NORMAN D CHAIRMAN, PRESIDENT, AND CEO

    • Officer
    • Director
    • 10% Owner
    		 4,832,487 2022-11-07 4

    SCHWARTZ ALICE N

    • 10% Owner
    • DIRECTOR EMERITUS
    		 7,276,588 2022-11-07 1

    ALLISON SCHWARTZ

    • Director
    		 3,890 2022-11-07 4

    DASKAL ILAN EVP, CHIEF FINANCIAL OFFICER

    • Officer
    		 2,037 2022-09-02 3

    LAST ANDREW J. EVP, CHIEF OPERATING OFFICER

    • Officer
    		 4,889 2022-09-02 3

    CROWLEY MICHAEL EVP, GBL COMMERCIAL OPERATIONS

    • Officer
    		 26,915 2022-09-02 2

    MAY SIMON EVP, PRESIDENT, LSG

    • Officer
    		 6,792 2022-09-02 2

    DAHOWSKI DIANE EVP, GLOBAL SUPPLY CHAIN

    • Officer
    		 42,032 2022-09-02 3

    TUMOLO ANNETTE EXECUTIVE VICE PRESIDENT

    • Officer
    		 13,358 2021-11-11 0

    HUTTON RONALD W VICE PRESIDENT AND TREASURER

    • Officer
    		 4,688 2020-09-11 0

    MAGNI GIOVANNI EVP, CHIEF STRATEGY OFFICER

    • Officer
    		 22,495 2020-09-10 0

    STARK JAMES R VP, CORPORATE CONTROLLER

    • Officer
    		 0 2019-11-11 0

    HERTIA JOHN EXECUTIVE VICE PRESIDENT

    • Officer
    		 18,980 2019-09-12 0

    TSINGOS CHRISTINE A EVP AND CFO

    • Officer
    		 6,683 2018-12-14 0

    GOETZ JOHN EVP, CHIEF OPERATING OFFICER

    • Officer
    		 66,473 2017-09-13 0

    HALL SHANNON EXECUTIVE VICE PRESIDENT

    • Officer
    		 565 2017-09-13 0

    HINCKLEY GREGORY K

    • Director
    		 500 2017-05-26 0

    EDWARDS JEFFREY L

    • Director
    		 0 2017-04-25 0

    PINKSTON ARNOLD A

    • Director
    		 0 2017-04-25 0

    PEI MELINDA LITHERLAND

    • Director
    		 0 2017-04-25 0

    SODERBERG SHAWN MARIE EVP, GENERAL COUNSEL, SEC

    • Officer
    		 652 2015-12-14 0

    MCCOMB JOEL

    • Director
    		 400 2014-07-23 0

    SCHWARTZ DAVID CHAIRMAN OF THE BOARD

    • Officer
    • Director
    • 10% Owner
    		 7,390,891 2011-12-14 0

    WADLER SANFORD VP, GENERAL COUNSEL, SECRETARY

    • Officer
    		 11,936 2011-12-14 0

    CRUTCHFIELD BRADFORD VICE PRESIDENT

    • Officer
    		 5,811 2011-11-16 0

    NEFF DEBORAH J

    • Director
    		 0 2011-10-26 0

    BENNETT JAMES

    • Director
    		 80,000 2010-11-19 0

    LOVE TED W

    • Director
    		 0 2010-03-24 0

    HILLMAN AL

    • Director
    		 15,160 2009-12-14 0

    DRAPEAU LOUIS

    • Director
    		 0 2007-02-14 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 M 150 $215.98 a 4,417 direct -1.8874 0.1723 1.0483 4 -1.9366 5

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 M 150 d 2,350 direct

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 S 746 $486.89 d 2,671 direct -1.8874 0.1723 1.0483 4 -1.9366 5

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 M 850 $159.32 a 4,267 direct -1.8874 0.1723 1.0483 4 -1.9366 5

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 M 850 d 0 direct

    ERNST TIMOTHY S - Officer EVP, GENERAL COUNSEL & SEC

    		2023-03-08 20:00:15 -0500 2023-03-08 S 1,000 $486.08 d 3,417 direct -1.8874 0.1723 1.0483 4 -1.9366 5

    RAMALINGAM AJIT - Officer SVP, CHIEF ACCOUNTING OFFICER

    		2023-02-14 14:30:00 -0500 2023-02-10 A 644 a 644 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    BIO-RAD LABORATORIES-A BIO 2023-03-24 15:45:03 UTC 4.57 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 15:15:03 UTC 4.57 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 14:45:03 UTC 4.32 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 14:15:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 13:45:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 13:15:04 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-24 12:45:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 22:15:04 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 21:45:04 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 21:15:04 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 20:45:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 20:15:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 19:45:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 19:15:03 UTC 4.32 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 18:45:04 UTC 4.32 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 18:15:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 17:45:03 UTC 4.32 0.25 900000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 17:15:03 UTC 4.32 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 16:45:04 UTC 4.32 0.25 950000
    BIO-RAD LABORATORIES-A BIO 2023-03-23 16:15:03 UTC 4.32 0.25 950000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    FundVantage Trust- Gotham Master Neutral Fund BIO -2.0 shares, $-1030.92 2020-09-30 N-PORT
    M3Sixty Funds Trust- AXS Market Neutral Fund BIO -161.0 shares, $-93853.34 2020-12-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Dynamic Equity Fund BIO -408.0 shares, $-234098.16 2021-01-31 N-PORT
    RUSSELL INVESTMENT CO- U.S. Small Cap Equity Fund BIO -257.0 shares, $-90389.47 2022-10-31 N-PORT
    Alger Funds II- Alger Dynamic Opportunities Fund BIO -1846.0 shares, $-649256.66 2022-10-31 N-PORT
    AdvisorShares Trust- AdvisorShares Dorsey Wright Short ETF BIO -940.0 shares, $-395260.6 2022-12-30 N-PORT
    FundVantage Trust- Gotham Hedged Core Fund BIO -74.0 shares, $-31116.26 2022-12-30 N-PORT
    FundVantage Trust- Gotham Enhanced 500 Plus Fund BIO -7.0 shares, $-2943.43 2022-12-30 N-PORT
    RUSSELL INVESTMENT FUNDS- U.S. Small Cap Equity Fund BIO -49.0 shares, $-20604.01 2022-12-31 N-PORT

    Congressional Transactions Past 6-Months

    To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***
    Congress Person Party Chamber Filing Filing Date Transaction Date Security Type Owner Transaction Amount
    Hon. Susie Lee democrat House Filing 2022-12-05 2022-11-30 JT S $1,001-$15,000
    Hon. Rohit Khanna democrat House Filing 2022-12-02 2022-11-03 SP P $1,001-$15,000
    Hon. Rohit Khanna democrat House Filing 2022-12-02 P $1,001-$15,000
    Hon. Rohit Khanna democrat House Filing 2022-11-02 2022-10-20 DC S $1,001-$15,000

    Elevate your investments